Qiagen NV (NYSE:QGEN)
| 46.07 Delayed Data As of May 26 |  +0.46 / +1.01%Today’s Change | 40.38 Today|||52-Week Range 51.18 | -7.62% Year-to-Date |
Latest QGEN News | Press Releases
| QIAGEN (QGEN) Expands Enzyme Offering to Aid Laboratory May 23 / Zacks.com - Paid Partner Content | Here's Why You Should Retain QIAGEN (QGEN) Stock for Now May 19 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 45.61 |
| Today’s open | 45.69 |
| Day’s range | 45.69 - 46.23 |
| Volume | 886,996 |
| Average volume (3 months) | 776,066 |
| Market cap | $10.5B |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | -17.29% |
| Earnings growth (this year) | -11.12% |
| Earnings growth (next 5 years) | +2.80% |
| Revenue growth (last year) | -4.89% |
| P/E ratio | 29.9 |
| Price/Sales | 5.36 |
| Price/Book | 3.03 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BRKRBruker Corp | +0.78 | +1.10% |
| BIOBio Rad Laboratories... | +6.05 | +1.62% |
| RVTYRevvity Inc | +0.15 | +0.13% |
| WATWaters Corp | +0.97 | +0.37% |
Data as of 4:00pm ET, 05/26/2023
Financials
| Next reporting date | August 1, 2023 |
| EPS forecast (this quarter) | $0.50 |
| Annual revenue (last year) | $2.1B |
| Annual profit (last year) | $423.2M |
| Net profit margin | 19.76% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Venlo, Limburg |
Forecasts
